$240MStrategic acquisitionHealthcare & Life SciencesCompleted
Agilent closes $240M Proscia digital-pathology deal
Agilent Technologies has completed its acquisition of Proscia, a provider of digital-pathology software for clinical and life-sciences customers. Agilent paid $240 million in cash at closing, with up to $30 million more tied to future performance milestones.
Why it matters: The deal moves Agilent further into software for digital pathology, a growing area of its clinical and life-sciences business.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.
Following healthcare M&A?
The day's biggest deals, healthcare included, in one five-minute email every morning. Built for dealmakers and investors. Free, with no paywalled links.
See what you get →